ReviewJournal of translational medicine2025

Immunometabolic reprogramming in lung cancer: interplay between immune and stem-like cells in immune checkpoint inhibitor resistance.

Ji-Yong Sung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.